A European acquirer contracts to purchase a UK-regulated financial services business. The deal team assumes the transaction will close within sixty days of signing. Three months later, the Financial Conduct Authority (FCA) approval process is still open, the competition filing has triggered a Phase 2 review, and the original closing conditions in the share purchase agreement (SPA) have expired. Renegotiation costs, extended exclusivity fees, and reputational strain follow – all of which could have been anticipated and managed with a properly sequenced regulatory plan from day one.
Cross-border mergers involving the United Kingdom require navigating a distinct post-Brexit regulatory system that combines English company law, UK competition legislation, and sector-specific financial regulation. The core procedural steps include satisfying all conditions in the SPA, obtaining any required competition or FCA clearance, and completing registration at Companies House (the UK's official company registry). Timelines range from three months for straightforward deals to over a year where parallel multi-jurisdictional approvals are needed.
This guide sets out the step-by-step process, documentary checklist, common errors by foreign acquirers, and a decision framework for choosing the right approach to a UK cross-border merger.
The UK regulatory setting after Brexit
Since the UK left the EU single market, cross-border mergers involving UK entities no longer benefit from the EU Cross-Border Mergers Directive. Each element of the transaction must satisfy UK domestic requirements independently. This has a direct effect on deal structuring and timeline planning.
Under UK company legislation, a merger can be achieved through several routes: a share acquisition, an asset acquisition, a statutory court-sanctioned scheme of arrangement, or a contractual business transfer. Each route carries different regulatory triggers. Choosing the wrong structure at the outset delays execution and can forfeit strategic value.
UK competition legislation gives the Competition and Markets Authority (CMA) broad powers to review and block transactions. The CMA operates a voluntary notification system for mergers below mandatory thresholds, but it retains the power to call in transactions up to four months after completion. A foreign acquirer who closes without assessing the CMA risk – assuming that voluntary means optional – can face post-closing investigation and, in serious cases, mandatory divestiture.
Sector-specific regulation adds a further layer. The FCA supervises change-of-control for authorised firms under financial services legislation. The Prudential Regulation Authority (PRA) applies equivalent oversight to banks and insurers. The National Security and Investment Act imposes mandatory notification requirements for acquisitions in defined sensitive sectors – ranging from artificial intelligence to defence and energy infrastructure. For a foreign acquirer in any of these categories, closing before obtaining approval is not merely inadvisable; it is unlawful and renders the transaction void.
For businesses also operating in Portugal or other EU markets, the interaction between UK and EU regulatory approvals adds complexity. Our guide to cross-border mergers involving Portugal addresses the EU dimension in detail.
Step-by-step process: from due diligence to closing
Step 1 – Due diligence and structure selection (weeks 1–6)
Effective due diligence in a UK cross-border context covers legal, financial, tax, and regulatory dimensions simultaneously. The legal due diligence review examines the target's constitutional documents, material contracts, employment arrangements, intellectual property ownership, and litigation exposure. The regulatory review identifies whether the target holds any FCA or PRA authorisation. Whether it operates in a sector covered by national security legislation. Additionally, whether its turnover or share of supply meets the CMA jurisdictional thresholds.
Structure selection follows directly from due diligence findings. A share acquisition transfers the target entity – including all liabilities – to the acquirer. An asset acquisition allows selective transfer of identified assets and contracts, leaving unwanted liabilities behind. A scheme of arrangement requires High Court sanction and is typically used for public company mergers. Each structure has distinct stamp duty, tax, and employment law consequences under UK legislation.
Step 2 – Negotiating and signing the SPA (weeks 4–10)
The share purchase agreement is the central transaction document. In UK M&A practice, the SPA contains the agreed purchase price and adjustment mechanisms, representations and warranties given by the seller about the target's condition. Additionally. A set of closing conditions that must be satisfied before completion can occur. Closing conditions typically include competition clearance, FCA approval (if applicable), and national security clearance where the sector is designated.
Warranty and indemnity insurance is now widely used in UK cross-border deals. It allows the acquirer to claim under an insurance policy rather than directly against the seller. This mechanism shortens escrow periods and facilitates cleaner exits for seller-side private equity. Foreign acquirers unfamiliar with this instrument sometimes resist it as unnecessary cost. In practice, it reduces completion risk and broadens the warranty coverage available.
Step 3 – Competition filing and CMA review (weeks 6–30+)
Where the target's UK turnover exceeds the threshold set in UK competition legislation, or where the combined share of supply test is met, the parties must consider a formal CMA filing. The CMA's Phase 1 review runs for up to 40 working days. If the CMA identifies concerns, it may accept remedies or open a Phase 2 investigation, which can extend for an additional 24 weeks. A deal that clears at Phase 1 within the standard period adds roughly two to three months to the overall timeline. A Phase 2 referral adds six months or more.
Many foreign acquirers underestimate the CMA's willingness to open Phase 2 investigations. The CMA has demonstrated a notably independent posture since Brexit, applying its own analytical standards rather than deferring to European Commission assessments of the same transaction. Where a deal also requires European Commission review, the two processes run in parallel but are not coordinated. Separate legal teams and separate economic submissions are required for each authority.
Step 4 – FCA and PRA change-of-control approval (weeks 6–24)
Where the target is FCA-authorised, the acquirer must submit a change-of-control notification before closing. The FCA has 60 working days to assess the application, with a possible extension to 90 working days where supplementary information is requested. The assessment examines the acquirer's financial soundness, fitness and propriety, and the proposed business plan for the target post-acquisition.
A common error by foreign buyers is submitting an incomplete notification to reduce preparation time. An incomplete submission pauses the statutory clock and restarts the assessment period. This can add weeks to the timeline and signal to the FCA that the acquirer lacks the organisational capacity to manage a regulated entity. Practitioners experienced in UK cross-border M&A prepare FCA submissions in full before filing, not incrementally in response to FCA queries.
For detailed transactional support across the full process, our M&A advisory services in the United Kingdom provide end-to-end guidance from structure selection through to completion.
Step 5 – National security clearance (weeks 1–30)
The National Security and Investment Act introduced mandatory pre-closing notification for acquisitions above prescribed thresholds in 17 designated sectors. Closing before clearance is issued renders the transaction void and may attract civil or criminal penalties. The review period is 30 working days at the initial screening stage, extendable to 45 working days where a call-in notice is issued, with a further possible extension for detailed investigation.
The breadth of the designated sectors surprises many foreign acquirers. A technology company providing data analytics to infrastructure clients, a logistics business with government contracts, or an engineering firm supplying components to defence primes can all fall within scope. Sector classification should be assessed by specialist counsel before heads of terms are agreed – not after signing.
Step 6 – Satisfaction of closing conditions and completion (weeks 12–52+)
Once all regulatory approvals are in hand, the parties work through the closing conditions checklist in the SPA. This typically involves board resolutions approving the transaction, delivery of executed stock transfer forms, payment of the purchase price, and simultaneous exchange of completion deliverables. Where the deal involves a cross-border element – for example, a Portuguese seller transferring shares in a UK company – the closing mechanics must be synchronised across both legal systems.
Post-closing filings at Companies House must be completed within the statutory period. HMRC (His Majesty's Revenue and Customs) stamp duty and stamp duty land tax must be paid promptly. Employment law notifications under UK legislation apply where the transaction constitutes a relevant transfer of employees. Failure to meet post-closing deadlines generates fines and administrative complications that accumulate quickly.
To explore how UK corporate law obligations interact with the transactional process, see our overview of corporate law services in the United Kingdom.
To receive an expert assessment of your cross-border merger in the United Kingdom, contact us at info@ferrazwhitmore.com.
Documentary checklist for a UK cross-border merger
The following documents are typically required at various stages of a UK cross-border merger. The precise list varies by deal structure and sector.
Pre-signing documents:
- Heads of terms or letter of intent (non-binding, setting commercial parameters)
- Non-disclosure agreement governing due diligence information exchange
- Due diligence report covering legal, financial, tax, and regulatory matters
- Competition and regulatory pre-assessment memorandum
Transaction documents:
- Share purchase agreement – including representations and warranties, closing conditions, and price adjustment mechanisms
- Disclosure letter from seller qualifying the SPA warranties
- Warranty and indemnity insurance policy (where applicable)
- Board resolutions of buyer and seller entities approving the transaction
Regulatory filings:
- CMA merger notification (where thresholds are met)
- FCA change-of-control notification (where target is FCA-authorised)
- National Security and Investment Act notification (where designated sector is involved)
- PRA notification (where target is PRA-regulated)
Post-closing filings:
- Stock transfer forms and Companies House confirmation of ownership change
- HMRC stamp duty payment documentation
- Employment law notifications where TUPE (Transfer of Undertakings regulations) applies
- Updated statutory registers of the target company
Missing or incorrectly executed documents at closing – particularly stock transfer forms and board resolutions – are among the most common causes of post-closing disputes between foreign buyers and UK sellers. A document checklist agreed between legal teams at least four weeks before the scheduled closing date materially reduces this risk.
Common errors by foreign acquirers and how to avoid them
Foreign buyers approaching a UK cross-border merger for the first time encounter a legal system with specific procedural requirements that differ sharply from civil law systems. Several errors recur with regularity.
Underestimating the CMA's independence. Post-Brexit, the CMA is no longer bound by European Commission decisions on the same transaction. A merger cleared by the Commission at EU level may still attract a CMA investigation. Foreign acquirers who treat UK competition filing as a formality – because the deal cleared elsewhere – find themselves unprepared for a substantive Phase 2 review. The CMA's analytical approach is rigorous and its remedies can include structural divestiture.
Treating the SPA as a standard template. UK M&A practice has developed a sophisticated set of warranty and indemnity conventions. The scope of representations and warranties, the cap on liability, and the basket threshold are all negotiated variables. Foreign sellers in particular sometimes accept standard buyer-friendly terms without appreciating that the warranty regime in the UK is substantially broader than in many civil law jurisdictions. Specialist negotiation of the SPA protects the seller's financial exposure post-closing.
Leaving tax structuring to the end. HMRC imposes stamp duty on share acquisitions and stamp duty land tax on property transfers. UK tax legislation also contains anti-avoidance rules that apply to cross-border reorganisations. Structuring decisions made at the outset – before heads of terms are signed – determine the tax burden on the transaction. Retrofitting tax-efficient structures after the SPA is signed is rarely possible and often costly.
Failing to identify TUPE obligations early. Where a cross-border deal involves the transfer of a UK business or part of a business, employment legislation may require that employees transfer automatically on their existing terms. Foreign acquirers who plan post-acquisition workforce restructuring without understanding TUPE obligations face employment tribunal claims. Early employment law advice shapes both the deal structure and the integration plan.
Signing before national security assessment. The consequences of closing a notifiable transaction without clearance under the national security regime are severe. The transaction is void. The acquirer may face enforcement action. Courts in the United Kingdom have confirmed that the voidness consequence cannot be waived by contractual agreement between the parties. This is a non-negotiable procedural requirement, and its assessment must precede signing.
Decision framework: choosing the right approach
A cross-border merger involving the United Kingdom is appropriate if the following conditions are present:
- The target operates primarily in the UK and its value is tied to UK-registered assets, contracts, or regulatory permissions
- The acquirer can satisfy the FCA's or PRA's fitness and propriety standards if the target is regulated
- The combined entity will not raise material concerns under UK competition legislation (or the acquirer is prepared for a CMA review process)
- The target's sector does not trigger mandatory national security notification, or the acquirer is prepared to seek clearance
Before initiating the process, verify the following critical points:
- Has a regulatory pre-assessment been completed covering competition, national security, and financial services legislation?
- Has the SPA been reviewed by counsel experienced in UK M&A conventions, including the warranty and indemnity regime?
- Have HMRC stamp duty costs been modelled into the deal economics?
- Have TUPE obligations been assessed where a business transfer is involved?
- Is a realistic timeline built into the SPA closing conditions, allowing for the longest expected regulatory process?
The deal structure decision follows a clear hierarchy. Where the target is a clean company with no legacy liabilities, a share acquisition through an SPA is the most straightforward route. Where legacy liabilities are uncertain or the target holds assets in multiple jurisdictions, an asset acquisition or a structured business transfer may be preferable. Where the target is a publicly listed UK company, a scheme of arrangement sanctioned by the High Court is the standard mechanism – but it requires court approval and takes longer than a private deal.
A scenario that frequently arises in cross-border practice involves a Continental European strategic buyer acquiring a UK mid-market company in a regulated sector. The deal economics are clear. The SPA is negotiated quickly. But if the regulatory timeline is not built in from the start, the original closing date passes, the SPA's long-stop date is triggered, and either party can walk away. The cost of that outcome – abandoned deal fees, adviser costs, and management distraction – often exceeds the cost of a thorough regulatory pre-assessment at the outset.
If the situation shifts during the process – for example, if the CMA opens a Phase 2 investigation after signing – the deal transforms from a standard commercial transaction into a contested regulatory proceeding. At that point, the matter requires specialist competition litigation support, economic expert engagement, and a revised deal timeline. Identifying this trigger early allows the parties to build Phase 2 costs and remedies into the SPA at the negotiation stage rather than renegotiating under pressure.
For a tailored strategy on cross-border merger approvals in the United Kingdom, reach out to info@ferrazwhitmore.com.
Frequently asked questions
Q: How long does a cross-border merger involving the United Kingdom typically take from signing to completion?
A: A straightforward cross-border deal can close within three to four months of signing. Transactions requiring UK competition clearance or FCA approval typically extend to six to twelve months. Complex multi-jurisdictional deals with parallel regulatory processes in two or more countries can take longer still.
Q: Does a foreign acquirer always need FCA approval to buy a UK-regulated business?
A: Not always. FCA change-of-control approval is required when the target holds an FCA authorisation and the acquirer will cross a prescribed ownership threshold. Where the target's regulated activities are only incidental to its main business, or where the acquirer falls below the threshold, FCA pre-approval may not be triggered. Legal advice is essential before assuming no regulatory consent is needed.
Q: Is it a common misconception that Companies House registration alone completes a UK merger?
A: Yes. Engaging a lawyer in the United Kingdom with cross-border M&A experience is important precisely because Companies House filing is only the final administrative step. Competition filings, FCA approvals, HMRC notifications, and the satisfaction of all closing conditions in the share purchase agreement must come first. Filing before these are resolved can create significant legal exposure.
About Ferraz & Whitmore
Ferraz & Whitmore is an international law firm based in Lisbon, advising business clients across 46 jurisdictions. Our team combines Portuguese civil law expertise with English common law tradition to deliver cross-border legal solutions in M&A transactions. including complex mergers involving UK-regulated entities, multi-jurisdictional SPA negotiations, and CMA and FCA approval processes. We work with international entrepreneurs, institutional investors, and in-house legal teams who need results-oriented counsel across multiple legal systems. As an international law firm in the United Kingdom context, our M&A practice covers the full spectrum of regulatory approvals, from competition filings before the CMA to change-of-control notifications under financial services legislation. The firm's M&A practice spans both civil law and common law systems, and our attorneys have advised on share and asset acquisitions across Europe, the Americas, and the Middle East. Ferraz & Whitmore is a member of leading international legal associations and participates in cross-border practice groups focused on corporate transactions and regulatory compliance. To discuss your cross-border merger in the United Kingdom, contact us at info@ferrazwhitmore.com.
Disclaimer: This publication is provided for informational purposes only and does not constitute legal advice. The information herein should not be relied upon as a substitute for professional legal counsel tailored to your specific circumstances. Ferraz & Whitmore assumes no liability for actions taken or not taken based on the contents of this material. For advice regarding your particular situation, please contact info@ferrazwhitmore.com.